Schrödinger's industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com.
解锁市场时间线与信号动态
新增 招聘 活动 — 刚出现 1 个新信号。
该公司进入各个市场的顺序 — 从最早到最新
Applications Scientist, Materials Science, Japan
Accelerating amorphous solid dispersion (ASD) formulation with Schrödinger’s Materials Science Suite [Webinar]
注册以查看完整信号动态
Schrödinger 的国际扩张与竞争对手的对比情况
Schrödinger你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Schrödinger你 | 4 | 0 | -15% | 37 | 30 |
Strategic Deployment Manager, Life Science
查看职位Greater Munich Metropolitan Area · 上周
Strategic Deployment Manager, Life Science
查看职位Germany · 上周
Strategic Deployment Manager
查看职位Greater Tokyo Area · 2周前
De-risk ASD Formulation—Before You Hit the Lab
已结束
Accelerating amorphous solid dispersion (ASD) formulation with Schrödinger’s Materials Science Suite [Webinar]
已结束
Accelerating amorphous solid dispersion (ASD) formulation with Schrödinger’s Materials Science Suite [Webinar]
已结束启明创投支持的英矽智能在港交所上市，成为2025年最大生物科技IPO，市值195.1亿港元。该AI驱动的药物研发公司致力于延长人类健康寿命。
启明创投周志峰位列福布斯2026年全球最佳创投人榜第80位,为首位上榜中国科技AI投资人。其投资组合包括壁仞科技、智谱等AI企业。
启明创投管理合伙人周志峰首次登上福布斯2026年全球最佳创投人榜第80位,凭借其在人工智能和科技领域的投资成就,2026年已有四家投资组合公司上市。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Schrödinger 的业务、市场和增长信号的快速解答。
